Similar articles for PMID: 16334162

Year	Number of Results
1993	1
1996	2
1997	1
1998	2
1999	2
2000	1
2002	1
2003	3
2004	5
2005	12
2006	10
2007	17
2008	14
2009	8
2010	4
2011	4
2012	6
2013	2
2014	2
2016	1
2017	2
2018	2
2019	1
2022	0

1

Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer.

Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Ogawa J. Kawai H, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4693-8. Anticancer Res. 2005. PMID: 16334162 Free article.

2

Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.

Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J, Dmitrovsky E. Rusch V, et al. Clin Cancer Res. 1997 Apr;3(4):515-22. Clin Cancer Res. 1997. PMID: 9815714

3

Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.

Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y, Ogawa J. Kawai H, et al. Clin Cancer Res. 2005 Jul 15;11(14):5084-9. doi: 10.1158/1078-0432.CCR-05-0200. Clin Cancer Res. 2005. PMID: 16033821

4

Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E. Rusch V, et al. Cancer Res. 1993 May 15;53(10 Suppl):2379-85. Cancer Res. 1993. PMID: 7683573

5

Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.

Cox G, Jones JL, O'Byrne KJ. Cox G, et al. Clin Cancer Res. 2000 Jun;6(6):2349-55. Clin Cancer Res. 2000. PMID: 10873086

6

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.

Na II, Rho JK, Choi YJ, Kim CH, Park JH, Koh JS, Ryoo BY, Yang SH, Lee JC. Na II, et al. Lung Cancer. 2007 Jul;57(1):96-102. doi: 10.1016/j.lungcan.2007.01.027. Epub 2007 Mar 6. Lung Cancer. 2007. PMID: 17337084

7

Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.

Nose N, Sugio K, Oyama T, Nozoe T, Uramoto H, Iwata T, Onitsuka T, Yasumoto K. Nose N, et al. J Clin Oncol. 2009 Jan 20;27(3):411-7. doi: 10.1200/JCO.2008.18.3251. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064969

8

Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.

Volante M, Saviozzi S, Rapa I, Ceppi P, Cappia S, Calogero R, Novello S, Borasio P, Papotti M, Scagliotti GV. Volante M, et al. Cancer. 2007 Sep 15;110(6):1321-8. doi: 10.1002/cncr.22903. Cancer. 2007. PMID: 17647268 Free article.

9

The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.

Ciledağ A, Kaya A, Yetkin O, Poyraz B, Savaş I, Numanoğlu N, Savaş H. Ciledağ A, et al. Tuberk Toraks. 2008;56(4):390-5. Tuberk Toraks. 2008. PMID: 19123074

10

Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.

Sarkaria IS, Zakowski MF, Pham D, Hezel M, Ebright MI, Chuai S, Venkatraman ES, Kris MG, Rusch VW, Singh B. Sarkaria IS, et al. Ann Thorac Surg. 2008 Jan;85(1):216-23. doi: 10.1016/j.athoracsur.2007.07.046. Ann Thorac Surg. 2008. PMID: 18154814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed